FDA Clears Igalmi as First Home Option for Agitation in Schizophrenia, Bipolar Disorder
An FDA decision lets adults with schizophrenia-related illness or bipolar disorder use Igalmi, a film that dissolves in the mouth, at home during agitation episodes.
Fact checked by NewsPlainVerified by NewsPlain: confirmed by at least two named sources
Brief
The FDA approved home use of Igalmi on Nov. 16, 2026, for adults whose schizophrenia-related illness or bipolar disorder brings on…
More reporting and context continue here.
The complete story is available with Premium.
Read the facts, open questions and supporting sources.
Continue reading with NewsPlain Premium.
Keep reading with NewsPlain Premium
Get the full brief, the full story, what's confirmed, what's still unclear, why it matters, and every source.
5 confirmed facts, 1 open question and 3 sources behind this story.